Reduced Expression of Jumonji AT-Rich Interactive Domain 2 (JARID2) in Glioma Inhibits Tumor Growth In Vitro and In Vivo

Jumonji AT-rich interactive domain 2 (JARID2) is a member of the Jumonji family of proteins and has been proposed as an oncogene in several types of human cancer. However, the role of JARID2 in human glioma has not yet been understood. The present study was designed to determine the roles of JARID2...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhenjiang, Xu, Chenyang, Gao, Ming, Ding, Bingqian, Wei, Xinting, Ji, Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cognizant Communication Corporation 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841153/
https://www.ncbi.nlm.nih.gov/pubmed/27641964
http://dx.doi.org/10.3727/096504016X14738135889976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841153/
https://www.ncbi.nlm.nih.gov/pubmed/27641964
http://dx.doi.org/10.3727/096504016X14738135889976

Ejemplares similares